Literature DB >> 1530578

The interrelationships of the inositol phosphates formed in vasopressin-stimulated WRK-1 rat mammary tumour cells.

C J Barker1, N S Wong, S M Maccallum, P A Hunt, R H Michell, C J Kirk.   

Abstract

1. Temporal changes in the levels of many inositol phosphates, whose structural characterization is presented in the preceding paper [Wong, Barker, Morris, Craxton, Kirk & Michell (1991) Biochem. J. 286, 459-468], have been monitored in vasopressin-stimulated WRK-1 cells. 2. Upon stimulation, Ins(1,4,5)P3 accumulated within 1 s, consistent with its role as a rapidly acting second messenger produced by receptor activation of phosphoinositidase C. Ins(1,4)P2 and Ins(1,3,4,5)P4, both of which are immediate products of Ins(1,4,5)P3 metabolism, also accumulated quickly. Ins4P, Ins(1,3,4)P3, Ins(3,4)P2, Ins(1,3)P2, Ins1P and Ins3P, which are intermediates in the metabolism of Ins(1,4)P2 and Ins(1,3,4,5)P4 to inositol, accumulated after seconds or within a few minutes, and in a temporal sequence consistent with their known metabolic interrelationships. 3. The stimulated accumulation of Ins(1,3,4,6)P4 was delayed, as expected if it is formed by phosphorylation of Ins(1,3,4)P3. 4. Ins(3,4,5,6)P4 accumulated 2-3-fold in a few minutes, and mainly before Ins(1,3,4,6)P4. 5. Using a [3H]-/[14C]-inositol double-labelling protocol, we obtained evidence that all of the compounds that accumulated upon stimulation, except Ins(3,4,5,6)P4, originated from lipid-derived Ins(1,4,5)P3, but that the newly formed Ins(3,4,5,6)P4 came from a different source. 6. There were no consistent changes in the levels of Ins(1,3,4,5,6)P5 and InsP6 during stimulation. 7. Alongside the gradual accumulation of Ins(1:2-cyclic,4,5)P3 during stimulation [Wong, Barker, Shears, Kirk & Michell (1988) Biochem. J. 252, 1-5], there was an accumulation of Ins(1:2-cyclic,4)P2 and Ins(1:2-cyclic)P, probably as either minor side products of phosphoinositidase C action or metabolites of Ins(1:2-cyclic,4,5)P3. 8. When Li+ was present during stimulation, it redirected the dephosphorylation pathways downstream of Ins(1,4,5)P3 in the manner expected from its inhibition of inositol monophosphatase and Ins(1,4)P2/Ins(1,3,4)P3 1-phosphatase: there were marked increases in the accumulation of Ins(1,4)P2 and Ins(1,3,4)P3 and of monophosphates. Moreover, Li+ shifted the Ins1P/Ins3P balance in favour of Ins1P, thus demonstrating redirection of the metabolism of the accumulated Ins(1,3,4)P3 towards Ins(1,3)P2 rather than Ins(3,4)P2.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1530578      PMCID: PMC1132921          DOI: 10.1042/bj2860469

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Metabolism of D-myo-inositol 1,3,4,5-tetrakisphosphate by rat liver, including the synthesis of a novel isomer of myo-inositol tetrakisphosphate.

Authors:  S B Shears; J B Parry; E K Tang; R F Irvine; R H Michell; C J Kirk
Journal:  Biochem J       Date:  1987-08-15       Impact factor: 3.857

2.  Stepwise phosphorylation of myo-inositol leading to myo-inositol hexakisphosphate in Dictyostelium.

Authors:  L R Stephens; R F Irvine
Journal:  Nature       Date:  1990-08-09       Impact factor: 49.962

3.  Inositol 1,2-cyclic 4,5-trisphosphate is not a product of muscarinic receptor-stimulated phosphatidylinositol 4,5-bisphosphate hydrolysis in rat parotid glands.

Authors:  P T Hawkins; C P Berrie; A J Morris; C P Downes
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

Review 4.  myo-inositol metabolites as cellular signals.

Authors:  C P Downes; C H Macphee
Journal:  Eur J Biochem       Date:  1990-10-05

5.  Stimulus-responsive and rapid formation of inositol pentakisphosphate in cultured adrenal chromaffin cells.

Authors:  N Sasakawa; T Nakaki; R Kato
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

6.  Synthesis of myo-inositol 1,3,4,5,6-pentakisphosphate from inositol phosphates generated by receptor activation.

Authors:  L R Stephens; P T Hawkins; C J Barker; C P Downes
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

Review 7.  Inositol phosphates in receptor-mediated cell signaling: metabolic origins and interrelationships.

Authors:  C J Kirk; S H Maccallum; R H Michell; C J Barker
Journal:  Biotechnol Appl Biochem       Date:  1990-10       Impact factor: 2.431

8.  Inositol 1:2(cyclic),4,5-trisphosphate is not a major product of inositol phospholipid metabolism in vasopressin-stimulated WRK1 cells.

Authors:  N S Wong; C J Barker; S B Shears; C J Kirk; R H Michell
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

9.  The use of cells doubly labelled with [14C]inositol and [3H]inositol to search for a hormone-sensitive inositol lipid pool with atypically rapid metabolic turnover.

Authors:  S H Maccallum; C J Barker; P A Hunt; N S Wong; C J Kirk; R H Michell
Journal:  J Endocrinol       Date:  1989-07       Impact factor: 4.286

10.  Specificity of inositol phosphate-stimulated Ca2+ mobilization from Swiss-mouse 3T3 cells.

Authors:  R F Irvine; A J Letcher; D J Lander; M J Berridge
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

View more
  11 in total

Review 1.  Defining signal transduction by inositol phosphates.

Authors:  Stephen B Shears; Sindura B Ganapathi; Nikhil A Gokhale; Tobias M H Schenk; Huanchen Wang; Jeremy D Weaver; Angelika Zaremba; Yixing Zhou
Journal:  Subcell Biochem       Date:  2012

2.  Metabolic evidence for the order of addition of individual phosphate esters in the myo-inositol moiety of inositol hexakisphosphate in the duckweed Spirodela polyrhiza L.

Authors:  C A Brearley; D E Hanke
Journal:  Biochem J       Date:  1996-02-15       Impact factor: 3.857

3.  Thyroid-stimulating hormone rapidly stimulates inositol polyphosphate formation in FRTL-5 thyrocytes without activating phosphoinositidase C.

Authors:  J Singh; P Hunt; M C Eggo; M C Sheppard; C J Kirk; R H Michell
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

4.  The inositol phosphates in WRK1 rat mammary tumour cells.

Authors:  N S Wong; C J Barker; A J Morris; A Craxton; C J Kirk; R H Michell
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

5.  Turnover of inositol pentakisphosphates, inositol hexakisphosphate and diphosphoinositol polyphosphates in primary cultured hepatocytes.

Authors:  M C Glennon; S B Shears
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

6.  A new inositol 1,4,5-trisphosphate binding protein similar to phospholipase C-delta 1.

Authors:  T Kanematsu; Y Misumi; Y Watanabe; S Ozaki; T Koga; S Iwanaga; Y Ikehara; M Hirata
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

7.  Activation of PLC by an endogenous cytokine (GBP) in Drosophila S3 cells and its application as a model for studying inositol phosphate signalling through ITPK1.

Authors:  Yixing Zhou; Shilan Wu; Huanchen Wang; Yoichi Hayakawa; Gary S Bird; Stephen B Shears
Journal:  Biochem J       Date:  2012-12-01       Impact factor: 3.857

Review 8.  Molecular basis for the integration of inositol phosphate signaling pathways via human ITPK1.

Authors:  Stephen B Shears
Journal:  Adv Enzyme Regul       Date:  2009-01-03

9.  Complex changes in cellular inositol phosphate complement accompany transit through the cell cycle.

Authors:  Christopher J Barker; Joanne Wright; Philip J Hughes; Christopher J Kirk; Robert H Michell
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

10.  Inositol 1,2,3-trisphosphate and inositol 1,2- and/or 2,3-bisphosphate are normal constituents of mammalian cells.

Authors:  C J Barker; P J French; A J Moore; T Nilsson; P O Berggren; C M Bunce; C J Kirk; R H Michell
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.